Bibliography

Export 175 results:

Filters: Author is Penn,I. [Clear All Filters]

1991

Schroeder TJ, Pesce AJ, Ryckman FC, Tressler TP, Brunson ME, Pedersen SH, et al. Selection criteria for liver transplant donors. J Clin Lab Anal. 1991;5(4):275-7.

1990

Schroeder TJ, First MR, Mansour ME, Hurtubise PE, Hariharan S, Ryckman FC, et al. Antimurine antibody formation following OKT3 therapy. Transplantation. 1990;49(1):48-51.

Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990;323(25):1767-9.

Brunson ME, Balakrishnan K, Penn I. HLA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol. 1990;29(1):56-63.

Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1990:53-62.

1989

First MR, Smith RD, Weiss MA, Schroeder TJ, Kant KS, Munda R, et al. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation. Transplant Proc. 1989;21(1 Pt 2):1567-70.

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Immune monitoring during retreatment with OKT3. Transplant Proc. 1989;21(1 Pt 2):1753-4.

Schroeder TJ, Gremse DA, Mansour ME, Theuerling AW, Brunson ME, Ryckman FC, et al. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Transplant Proc. 1989;21(1 Pt 2):2299-301.

Hariharan S, First MR, Munda R, Penn I, Schroeder TJ, Fidler J, et al. Prednisone withdrawal in HLA-identical living related donor transplant recipients. Transplant Proc. 1989;21(1 Pt 2):1617-9.

Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Am J Kidney Dis. 1989;14(5 Suppl 2):14-8.

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Successful retreatment of allograft rejection with OKT3. Transplantation. 1989;47(1):88-91.

1988

Penn I. Cancers after cyclosporine therapy. Transplant Proc. 1988;20(1 Suppl 1):276-9.

Shah B, First MR, Munda R, Penn I, Fidler JP, Alexander JW. Current experience with renal transplantation in older patients. Am J Kidney Dis. 1988;12(6):516-23.

Baquero A, Penn I, Bannett A, Werner DJ, Kim P. Misdiagnosis of metastatic cerebral choriocarcinoma in female cadaver donors. Transplant Proc. 1988;20(5):776-7.

Penn I. Multiple myeloma in a renal transplant recipient. Am J Kidney Dis. 1988;11(2):201.

Penn I. Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev. 1988;12(40695):39-57.

Penn I. Transmission of cancer with donor organs. Transplant Proc. 1988;20(5):739-40.

1987

Penn I. Cancers following cyclosporine therapy. Transplant Proc. 1987;19(1 Pt 3):2211-3.

Penn I. Diabetes mellitus and the surgeon. Curr Probl Surg. 1987;24(9):535-603.

Penn I. Neoplastic consequences of transplantation and chemotherapy. Cancer Detect Prev Suppl. 1987;1:149-57.

1986

Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer. 1986;58(3):611-6.

Penn I, First MR. Development and incidence of cancer following cyclosporine therapy. Transplant Proc. 1986;18(2 Suppl 1):210-5.

First MR, Alexander JW, Wadhwa N, Penn I, Munda R, Fidler JP, et al. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. Transplant Proc. 1986;18(2 Suppl 1):132-5.

1984

Penn I. Cancer in cadaver kidney transplant patients. Surgery. 1984;95(3):377-8.

First MR, Vaidya PN, Maryniak RK, Weiss MA, Munda R, Fidler JP, et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation. 1984;38(6):607-12.

Pages